- Home
- IVD
- By Technology Types
- By Diseases Types
- By Product Types
- Research
- Resource
- Distributors
- Company
| Product Name | Anti-NXP2 Monoclonal Antibody |
| Catalog No. | RDMA-0099 |
| Description | Specifically targets Nuclear Matrix Protein 2, a critical biomarker for juvenile dermatomyositis and cancer-associated myositis in adults. |
| Category | Myositis Marker |
| Host Species | Mouse |
| Clonality | Monoclonal |
| Isotype | IgG1 |
| Form | Liquid |
| Concentration | 1.7 mg/mL |
| Purity | >95% |
| Purification | Protein A |
| Buffer | 0.01M PBS |
| Preservative | 0.05% ProClin |
| Application | ELISA/CLIA |
| Matching Antigen | Recombinant NXP2 |
| Sensitivity | High |
| Specificity | No TIF1-g cross |
| CV (%) | <6% |
| Storage | 2-8°C |
| Shelf Life | 36 Months |
| Stability | 10x Cycles |
| Titer | 1:500K |
| Protein Test | UV280 |
| Endotoxin | <1.0 EU/mg |
For research use only, not for clinical use.
|
There is no product in your cart. |
Copyright © 2026 Alta DiagenoTech. All rights reserved.
